Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Genentech - Wikipedia

    en.wikipedia.org/wiki/Genentech

    Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [5] Historically, the company is regarded as the world's first biotechnology company. [6]

  3. Roche - Wikipedia

    en.wikipedia.org/wiki/Roche

    On 2 January 2009, Roche acquired Memory Pharmaceuticals Corp. [23] On 26 March 2009, Roche acquired Genentech for $46.8 billion. [24] On 12 March 2009, Roche agreed to fully acquire Genentech, in which it had held a majority stake since 1990, [25] after eight months of negotiations.

  4. Aviv Regev - Wikipedia

    en.wikipedia.org/wiki/Aviv_Regev

    Aviv Regev (born 11 July 1971) [3] is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche. [4] She is a core member (on leave) at the Broad Institute of MIT and Harvard and professor (on leave) at the Department of Biology of the Massachusetts ...

  5. Genentech's great deal - AOL

    www.aol.com/news/2009-03-12-genentechs-great...

    Roche will finally buy Genentech (DNA) after months of fighting over a price for the acquisition. According to The Wall Street Journal (subscription required), "Swiss drug maker Roche Holding AG ...

  6. Genentech withdraws use of Gavreto in US for a type of ... - AOL

    www.aol.com/news/genentech-withdraws-gavreto-us...

    June 30, 2023 at 9:04 AM. (Reuters) - Genentech will withdraw Gavreto from use in the United States for treating a type of thyroid cancer as it was not feasible for the Roche unit to pursue the ...

  7. Roche launches recalled eye implant in US - AOL

    www.aol.com/news/roche-launches-recalled-eye...

    July 8, 2024 at 12:10 PM. (Reuters) -Genentech, a unit of Roche Group, said on Monday it has re-launched its eye implant, Susvimo, in the United States, following the end of a voluntary recall ...

  8. Hal V. Barron - Wikipedia

    en.wikipedia.org/wiki/Hal_V._Barron

    Hal V. Barron. Hal V. Barron (born 1962) is an American clinician-scientist and drug developer who served as president of research and development at GlaxoSmithKline from March 2018 [1] until 2022, when he resigned in order to join the cellular reprogramming venture Altos Labs in August of that year. [2] [3] [4] Prior to this he served as ...

  9. Marc Tessier-Lavigne - Wikipedia

    en.wikipedia.org/wiki/Marc_Tessier-Lavigne

    Frank Bradke ( postdoc) [ 1] Marc Trevor Tessier-Lavigne OC FRS FRSC FMedSci (born December 18, 1959) is a Canadian-American neuroscientist who was the eleventh president of Stanford University. [ 2][ 3] Previously, he was a professor at the University of California, San Francisco and then president of Rockefeller University in New York City ...